{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:36:19Z","timestamp":1740137779280,"version":"3.37.3"},"reference-count":85,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1055\/s-0043-1778032","type":"journal-article","created":{"date-parts":[[2024,1,12]],"date-time":"2024-01-12T00:13:38Z","timestamp":1705018418000},"page":"080-087","source":"Crossref","is-referenced-by-count":0,"title":["Thrombosis and Haemostasis 2023 Editors' Choice Papers"],"prefix":"10.1055","volume":"124","author":[{"given":"Christian","family":"Weber","sequence":"additional","affiliation":[{"name":"Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany"},{"name":"German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany"},{"name":"Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Rigby","sequence":"additional","affiliation":[{"name":"Institute for Cardiovascular Prevention (IPEK), LMU Munich, Munich, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-1626","authenticated-orcid":false,"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[{"name":"Liverpool Centre for Cardiovascular Science at University of Liverpool, Liverpool John Moores University and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom"},{"name":"Department of Clinical Medicine, Aalborg University, Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"issue":"06","key":"ref1","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1055\/a-2043-0346","article-title":"Factor XI inhibitors in early clinical trials: a meta-analysis","volume":"123","author":"M Galli","year":"2023","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref2","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1055\/a-1981-1763","article-title":"Assessment of DOAC in GEriatrics (Adage Study): rivaroxaban\/apixaban concentrations and thrombin generation profiles in NVAF very elderly patients","volume":"123","author":"G Foulon-Pinto","year":"2023","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/a-2021-8910","article-title":"Direct oral anticoagulants in the very elderly","volume":"123","author":"J W Eikelboom","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1769735","article-title":"The impact of polypharmacy on the effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","author":"M Grymonprez","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1769735","article-title":"Effect of oral anticoagulants in atrial fibrillation patients with polypharmacy: a meta-analysis","author":"Y Zheng","year":"2023","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref6","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1055\/s-0042-1756355","article-title":"Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF registry phase II and III","volume":"122","author":"G F Romiti","year":"2022","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"G YH Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u2018Atrial Fibrillation Better Care\u2019 pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"G F Romiti","year":"2022","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1055\/s-0043-1769612","article-title":"Mobile health-technology-integrated care for atrial fibrillation: a win ratio analysis from the mAFA-II randomized clinical trial","volume":"123","author":"G F Romiti","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1776900","article-title":"NOACs in atrial fibrillation patients with polypharmacy","author":"B Corica","year":"2023","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 focused update consensus guidelines of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation: executive summary","volume":"122","author":"T F Chao","year":"2022","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-0042-1760365","article-title":"Bleeding risk in elderly patients with venous thromboembolism who would have been excluded from anticoagulation trials","volume":"123","author":"C Schenker","year":"2023","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1055\/s-0043-1770100","article-title":"Risk of bleeding in liver cirrhosis receiving direct oral anticoagulants: a systematic review and meta-analysis","volume":"123","author":"Z Li","year":"2023","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref14","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1055\/a-2059-4737","article-title":"Residual venous obstruction as an indicator of clinical outcomes following deep vein thrombosis: a management study","volume":"123","author":"A FJ Iding","year":"2023","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref15","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/a-2102-0376","article-title":"Residual thrombosis: still relevant in the direct oral anticoagulant (DOAC) era?","volume":"123","author":"C Becattini","year":"2023","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref16","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1055\/a-1789-4824","article-title":"Managing uncertainty: physicians' decision making for stroke prevention for patients with atrial fibrillation and intracerebral hemorrhage","volume":"122","author":"E Ivany","year":"2022","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1055\/a-2068-6464","article-title":"Anticoagulant management and outcomes in nontraumatic intracranial hemorrhage complicated by venous thromboembolism: a retrospective chart review","volume":"123","author":"J Gorman","year":"2023","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1055\/a-2097-0775","article-title":"The hard bargain of anticoagulation after intracranial hemorrhage, in the setting of venous thromboembolism: between a rock and a hard place","volume":"123","author":"T J Milling Jr","year":"2023","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1055\/s-0043-1770096","article-title":"Factors influencing anti-Xa assays: a multicenter prospective study in critically ill and noncritically ill patients receiving unfractionated heparin","volume":"123","author":"D Lasne","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1055\/a-2107-0815","article-title":"Dynamic patterns and persistence of anticoagulation therapy in patients with venous thromboembolism in South Korea: a nationwide cohort study","author":"D Yoon","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1055\/a-2131-7066","article-title":"Patterns and persistence of anticoagulant use in the treatment of venous thromboembolism: insights from South Korea","author":"F Germini","year":"2023","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1055\/s-0042-1750385","article-title":"Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert consensus paper","volume":"122","author":"D A Gorog","year":"2022","journal-title":"Thromb Haemost"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1055\/a-2191-7627","article-title":"Dual antiplatelet (DAPT) or dual pathway inhibition (DPI)","author":"S Goto","year":"2023","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref24","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1055\/s-0040-1718729","article-title":"The East Asian paradox: an updated position statement on the challenges to the current antithrombotic strategy in patients with cardiovascular disease","volume":"121","author":"H K Kim","year":"2021","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0043-57030","article-title":"Comparison of de-escalation of DAPT intensity or duration in East Asian and Western patients with ACS undergoing PCI: a systematic review and meta-analysis","volume":"123","author":"D A Gorog","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1055\/a-2149-4344","article-title":"Guided anti-P2Y12 therapy in patients undergoing PCI: three systematic reviews with meta-analyses of randomized controlled trials with homogeneous design","author":"S Birocchi","year":"2023","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/a-1962-5447","article-title":"Increased von Willebrand factor platelet-binding capacity is related to poor prognosis in COVID-19 patients","volume":"123","author":"L Stefanini","year":"2023","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1055\/a-2087-3003","article-title":"Risk factors for postdischarge major thromboembolism and mortality in hospitalized patients with COVID-19 with cardiovascular comorbidities: insights from the CORE-19 registry","volume":"123","author":"D Giannis","year":"2023","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1055\/s-0042-1758655","article-title":"P2Y12 inhibition suppresses proinflammatory platelet-monocyte interactions","volume":"123","author":"C C Rolling","year":"2023","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref32","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1055\/a-2059-4844","article-title":"Atorvastatin versus placebo in ICU patients with COVID-19: ninety-day results of the INSPIRATION-S trial","volume":"123","author":"A H Talasaz","year":"2023","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref33","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1055\/s-0043-1768150","article-title":"Intravenous thrombolysis or medical management for minor strokes","volume":"123","author":"W-J Tu","year":"2023","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1055\/a-2077-5642","article-title":"The optimal management for people with acute stroke and minor deficits: intravenous thrombolysis or medical management?","volume":"123","author":"A C Cameron","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1055\/a-2106-3754","article-title":"Catheter-directed thrombolysis protocols for deep venous thrombosis of the lower extremities-a systematic review and meta-analysis","author":"L Duarte-Gamas","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1776009","article-title":"Catheter-directed thrombolysis for deep vein thrombosis: serving at break point","author":"G D Barnes","year":"2023","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref37","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/a-2031-3859","article-title":"Contemporary management and clinical course of acute pulmonary embolism: the COPE study","volume":"123","author":"C Becattini","year":"2023","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref38","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1055\/a-2019-0607","article-title":"Incidence of pregnancy-associated venous thromboembolism: second nationwide study","volume":"123","author":"H G Hwang","year":"2023","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1055\/s-0043-1769736","article-title":"Incidence and risk factors for pregnancy-associated venous thromboembolism: are there differences between east and west?","volume":"123","author":"C-T Tsai","year":"2023","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1055\/s-0043-1769592","article-title":"Venous thromboembolism in women of childbearing age: insights from the START registry","volume":"123","author":"E Grandone","year":"2023","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1055\/a-2125-3290","article-title":"Risk factors for venous thromboembolism in women of childbearing age","volume":"123","author":"K Xu","year":"2023","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref42","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0042-1760255","article-title":"Venous thromboembolism associated with assisted reproductive technology: a systematic review and meta-analysis","volume":"123","author":"M Goualou","year":"2023","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/a-1996-1341","article-title":"The legacy of Edwards and Steptoe and the windy roads of assisted reproduction: where do we stand with venous thromboembolism?","volume":"123","author":"E Grandone","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1776394","article-title":"Sex as a risk factor for atrial fibrillation-related stroke","author":"B Corica","year":"2023","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/a-1980-8852","article-title":"Genetic predisposition of both waist circumference and hip circumference increased the risk of venous thromboembolism","volume":"123","author":"J Wang","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-57018","article-title":"Obesity as a predictor for pulmonary embolism and performance of the age-adjusted D-dimer strategy in obese patients with suspected pulmonary embolism","author":"J O Gaugler","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1776010","article-title":"Venous thromboembolism and obesity: moving toward a better understanding of the population-attributable risk","author":"K A Martin","year":"2023","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref50","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1055\/s-0043-57225","article-title":"Prolonged fasting as a cause of deep vein thrombosis: a case report","volume":"7","author":"G Roberge","year":"2023","journal-title":"TH Open"},{"issue":"03","key":"ref51","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0042-1760257","article-title":"Protocol for a systematic review and individual participant data meta-analysis of randomized trials of screening for atrial fibrillation to prevent stroke","volume":"123","author":"W McIntyre","year":"2023","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref52","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1055\/a-2084-5018","article-title":"Hypercoagulability on thromboelastography can predict the functional outcomes in patients with acute ischemic stroke","volume":"123","author":"J-C Ryu","year":"2023","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1055\/s-0043-1771029","article-title":"Hypercoagulability state in predicting severe functional outcome in patients with acute ischemic stroke: cause, consequence, or both?","volume":"123","author":"M Paciaroni","year":"2023","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref54","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1055\/s-0043-1769609","article-title":"Risk factors of venous thromboembolic disease in cancer patients treated with immune checkpoint inhibitor","volume":"123","author":"J D le S\u00e8ve","year":"2023","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref55","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1055\/a-2121-9679","article-title":"Immune checkpoint inhibitors and venous thromboembolism: the more things change\u2026","volume":"123","author":"A A Khorana","year":"2023","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref56","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-0042-1758835","article-title":"Survival implications of thrombus recurrence or bleeding in cancer patients receiving anticoagulation for venous thromboembolism treatment","volume":"123","author":"R D McBane Ii","year":"2023","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref57","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1055\/a-2015-8597","article-title":"Recurrent thrombosis and bleeding in patients with cancer-associated venous thromboembolism receiving anticoagulation: are these modifiable risk factors for mortality?","volume":"123","author":"K Xu","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1055\/a-2145-7238","article-title":"A novel risk prediction score for clinically significant bleeding in patients anticoagulated for venous thromboembolism with active cancer","author":"A T Cohen","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1775582","article-title":"Predicting bleeding in cancer-associated venous thromboembolism: another milestone achieved","author":"V Rold\u00e1n","year":"2023","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref60","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1055\/s-0042-1759879","article-title":"Increased cancer risk in patients with kidney disease and venous thromboembolism: a population-based cohort study","volume":"123","author":"J R\u00f8nnow Sand","year":"2023","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref61","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1055\/a-2152-4762","article-title":"Kidney disease and cancer risk in patients with venous thromboembolism: what does it mean for clinical practice?","volume":"123","author":"S V Konstantinides","year":"2023","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref62","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1055\/s-0043-1770783","article-title":"Rivaroxaban versus apixaban for treatment of cancer-associated venous thromboembolism in patients at lower risk of bleeding","volume":"7","author":"K S Caroti","year":"2023","journal-title":"TH Open"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1055\/a-2191-7510","article-title":"Enoxaparin for the long-term therapy of venous thromboembolism in patients with cancer and renal insufficiency","author":"P Sig\u00fcenza","year":"2023","journal-title":"Thromb Haemost"},{"issue":"04","key":"ref64","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1055\/a-2000-8288","article-title":"Sleep apnea and incident unprovoked venous thromboembolism: data from the Pays de la Loire sleep cohort","volume":"123","author":"W Trzepizur","year":"2023","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref65","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1055\/a-2039-3222","article-title":"Developing validated tools to identify pulmonary embolism in electronic databases: rationale and design of the PE-EHR+ study","volume":"123","author":"B Bikdeli","year":"2023","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref66","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1055\/a-1986-8878","article-title":"Diagnostic accuracy of V\/Q and Q SPECT\/CT in patients with suspected acute pulmonary embolism: a systematic review and meta-analysis","volume":"123","author":"A Squizzato","year":"2023","journal-title":"Thromb Haemost"},{"issue":"07","key":"ref67","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/a-2057-8672","article-title":"Modern lung scintigraphy techniques for optimizing the diagnosis of pulmonary embolism: great expectations still awaiting to be met","volume":"123","author":"S Konstantinides","year":"2023","journal-title":"Thromb Haemost"},{"issue":"03","key":"ref68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0042-1760258","article-title":"Expression of microRNA predicts cardiovascular events in patients with stable coronary artery disease","volume":"123","author":"O B Pedersen","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1774310","article-title":"Neutrophil extracellular traps: potential prothrombotic state markers and therapeutic targets for atrial fibrillation","author":"X Liu","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1055\/a-2187-0645","article-title":"Are NETs a novel, exciting, thrombosis risk marker?","author":"G Wang","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1772221","article-title":"Plasma soluble glycoprotein VI, platelet function, bleeding, and ischemic events in patients undergoing elective percutaneous coronary intervention","author":"S Lahu","year":"2023","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref72","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1055\/s-0043-1764353","article-title":"Statin treatment is associated with alterations in the platelet lipidome","volume":"123","author":"T Harm","year":"2023","journal-title":"Thromb Haemost"},{"issue":"06","key":"ref73","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1055\/a-2052-9650","article-title":"Statin treatment and the alterations in the platelet lipidome: what is the impact of lipid profile on thrombosis?","volume":"123","author":"S Goto","year":"2023","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref74","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1055\/s-0043-1768162","article-title":"Adventitial vasa vasorum neovascularization in femoral artery of type 2 diabetic patients with macroangiopathy is associated with macrophages and lymphocytes as well as the occurrence of cardiovascular events","volume":"123","author":"D Chen","year":"2023","journal-title":"Thromb Haemost"},{"issue":"10","key":"ref75","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1055\/a-2116-7261","article-title":"Atherosclerotic plaque VASA vasorum in diabetic macroangiopathy: WHEN IS important, but also HOW IS needed","volume":"123","author":"L Badimon","year":"2023","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref76","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1055\/a-2149-4431","article-title":"Short-term western diet causes rapid and lasting alterations of bone marrow physiology","volume":"123","author":"M Bianchini","year":"2023","journal-title":"Thromb Haemost"},{"issue":"11","key":"ref77","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1055\/a-2091-7006","article-title":"Monocyte tissue factor expression: lipopolysaccharide induction and roles in pathological activation of coagulation","volume":"123","author":"A TA Sachetto","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1773763","article-title":"Reticulated platelets predict cardiovascular death and adverse events in coronary artery disease: a systematic review and meta-analysis","author":"D Bongiovanni","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1055\/a-2170-1892","article-title":"Reticulated platelets: a promising prognosis marker in cardiovascular diseases","author":"M A Esteve-Pastor","year":"2023","journal-title":"Thromb Haemost"},{"issue":"05","key":"ref80","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1055\/s-0043-1761419","article-title":"Decreased platelet reactivity and function in a mouse model of human pancreatic cancer","volume":"123","author":"T Kawano","year":"2023","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref81","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/a-1962-1613","article-title":"Impaired platelet function and thrombus formation in PDE5A-deficient mice","volume":"123","author":"X Gui","year":"2023","journal-title":"Thromb Haemost"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1055\/a-2186-6362","article-title":"Clinical and laboratory presentation and underlying mechanism in patients with Low VWF","author":"O Seidizadeh","year":"2023","journal-title":"Thromb Haemost"},{"issue":"02","key":"ref83","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1055\/a-2000-8406","article-title":"PDE5A: key enzyme to overcome platelet inhibition","volume":"123","author":"Z Nagy","year":"2023","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref84","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1055\/a-1896-6992","article-title":"CLEC-2 supports platelet aggregation in mouse but not human blood at arterial shear","volume":"122","author":"J H Bourne","year":"2022","journal-title":"Thromb Haemost"},{"issue":"12","key":"ref85","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1055\/a-1938-1380","article-title":"Of mice and man: the unwinding of CLEC-2 as an antithrombotic target?","volume":"122","author":"J D McFadyen","year":"2022","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref86","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1055\/a-2090-9739","article-title":"Modulation of extravascular binding of recombinant factor IX impacts the duration of efficacy in mouse models","volume":"123","author":"S K Machado","year":"2023","journal-title":"Thromb Haemost"},{"issue":"08","key":"ref87","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1055\/a-2068-0207","article-title":"Extravascular binding of coagulation factor IX gives hemostasis a boost","volume":"123","author":"J Pilch","year":"2023","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref88","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1055\/a-2057-8710","article-title":"Antibodies against noncatalytic B subunit of factor XIII inhibit activation of factor XIII and fibrin crosslinking","volume":"123","author":"M Souri","year":"2023","journal-title":"Thromb Haemost"},{"issue":"09","key":"ref89","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1055\/a-2077-3544","article-title":"Functional consequences of antibodies against noncatalytic B Subunit of factor XIII","volume":"123","author":"\u00c9 Katona","year":"2023","journal-title":"Thromb Haemost"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1778032.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T16:26:35Z","timestamp":1730823995000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0043-1778032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":85,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2024,1,11]]},"published-print":{"date-parts":[[2024,1]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1778032","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"type":"print","value":"0340-6245"},{"type":"electronic","value":"2567-689X"}],"subject":[],"published":{"date-parts":[[2024,1]]}}}